Evidence map›Paper›PMID 30185234›Full record

ArticleBiological research2018

Increased ROS production and DNA damage in monocytes are biomarkers of aging and atherosclerosis.

Thais A Jacinto, Giselle S Meireles, Ananda T Dias, Rafaela Aires, Marcella L Porto, Agata L Gava, Elisardo C Vasquez, Thiago Melo C Pereira, Bianca P Campagnaro, Silvana S Meyrelles

Open access · goldAbstract read
In one paragraph

Article in Biological research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. MCT-DependentBiology · 2023
    Article
  19. Biomarkers of aging.Science China. Life sciences · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Thais A JacintoLaboratory of Translational Physiology, Health Sciences Center, Federal University of Espirito Santo (UFES), Vitoria, Brazil.
Giselle S MeirelesLaboratory of Translational Physiology and Pharmacology, Pharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Rua Mercúrio, s/n, Boa Vista 1, Vila Velha, ES, 29102-623, Brazil.
Ananda T DiasLaboratory of Translational Physiology, Health Sciences Center, Federal University of Espirito Santo (UFES), Vitoria, Brazil.
Rafaela AiresLaboratory of Translational Physiology, Health Sciences Center, Federal University of Espirito Santo (UFES), Vitoria, Brazil.
Marcella L PortoFederal Institute of Education, Science and Technology (IFES), Vila Velha, ES, Brazil.
Agata L GavaLaboratory of Translational Physiology, Health Sciences Center, Federal University of Espirito Santo (UFES), Vitoria, Brazil.
Elisardo C VasquezLaboratory of Translational Physiology, Health Sciences Center, Federal University of Espirito Santo (UFES), Vitoria, Brazil.
Thiago Melo C PereiraLaboratory of Translational Physiology and Pharmacology, Pharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Rua Mercúrio, s/n, Boa Vista 1, Vila Velha, ES, 29102-623, Brazil.
Bianca P CampagnaroLaboratory of Translational Physiology and Pharmacology, Pharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Rua Mercúrio, s/n, Boa Vista 1, Vila Velha, ES, 29102-623, Brazil. biancacampagnaro@yahoo.com.br.ORCID http://orcid.org/0000-0002-9023-4892
Silvana S MeyrellesLaboratory of Translational Physiology, Health Sciences Center, Federal University of Espirito Santo (UFES), Vitoria, Brazil.
Universidade Federal do Espírito Santo · BRUniversidade Vila Velha · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico (BR) 303001/2015-1Conselho Nacional de Desenvolvimento Científico e Tecnológico (BR) 307584/2015-1Conselho Nacional de Desenvolvimento Científico e Tecnológico (BR) 445080/2014-0Conselho Nacional de Desenvolvimento Científico e Tecnológico (BR) 445736/2014-3
6 · The paper itself

Abstract

backgroundNew evidence demonstrates that aging and dyslipidemia are closely associated with oxidative stress, DNA damage and apoptosis in some cells and extravascular tissues. However, in monocytes, which are naturally involved in progression and/or resolution of plaque in atherosclerosis, this concurrence has not yet been fully investigated. In this study, we evaluated the influence of aging and hypercholesterolemia on serum pro-inflammatory cytokines, oxidative stress, DNA damage and apoptosis in monocytes from apolipoprotein E-deficient (apoE

resultsBesides the expected differences in serum lipid profile and plaque formation, we observed that atherosclerotic mice exhibited a significant increase in monocytosis and in serum levels of pro-inflammatory cytokines compared to WT mice. Moreover, it was observed that the overproduction of ROS, led to an increased DNA fragmentation and, consequently, apoptosis in monocytes from normocholesterolemic old mice, which was aggravated in age-matched atherosclerotic mice.

conclusionsIn this study, we demonstrate that a pro-inflammatory systemic status is associated with an impairment of functionality of monocytes during aging and that these parameters are fundamental extra-arterial contributors to the aggravation of atherosclerosis. The present data open new avenues for the development of future strategies with the purpose of treating atherosclerosis.

Indexed as

AgingAnimalsApoptosisAtherosclerosisBiomarkersDisease Models, AnimalDNA DamageHyperlipidemiasMaleMiceMice, Inbred C57BLMonocytesOxidative StressPlaque, AtheroscleroticReactive Oxygen SpeciesBiomarkersReactive Oxygen SpeciesapoE knockout miceApoptosisAtherosclerosisProinflammatory cytokines

Identifiers

PMID30185234
PMCPMC6123971
OpenAlexW2891747209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.